Filing Details
- Accession Number:
- 0001144204-10-019116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-08 13:00:00
- Reporting Period:
- 2010-03-31
- Filing Date:
- 2010-04-08
- Accepted Time:
- 2010-04-08 15:09:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
892160 | Derma Sciences Inc. | DSCI | Surgical & Medical Instruments & Apparatus (3841) | 232328753 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1365190 | Ltd Zealand New Comvita | Wilson Road South Private Bag 1 Te Puke Q2 3189 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-03-31 | 858,333 | $0.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series Q Warrants | Disposition | 2010-03-31 | 133,333 | $0.00 | 133,333 | $5.50 |
Common Stock | Series N Warrants | Disposition | 2010-03-31 | 100,000 | $0.00 | 100,000 | $6.25 |
Common Stock | Series H Warrants | Disposition | 2010-03-31 | 52,084 | $0.00 | 52,084 | $8.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-02-23 | 2015-02-23 | No | 4 | S | Direct |
0 | 2010-02-23 | 2015-02-23 | No | 4 | S | Direct |
0 | 2006-04-18 | 2011-04-30 | No | 4 | S | Direct |
Footnotes
- The securities reported herein were originally issued to the Reporting Person, Comvita New Zealand Limited. Comvita New Zealand Limited is a wholly-owned subsidiary of Comvita Limited, the parent corporation. The securities reported herein were subsequently distributed by Comvita New Zealand Limited to Comvita Limited without payment of cash consideration. The distribution from Comvita New Zealand Limited to Comvita Limited effected a change in the form of beneficial ownership exempt under Rule 16a-13.